In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
In the latest session, Clover Health Investments Corp (NASDAQ: CLOV) closed at $3.31 down -2.65% from its previous closing price of $3.40. In other words, the price has decreased by -$2.65 from its previous closing price. On the day, 6.24 million shares were traded. CLOV stock price reached its highest trading level at $3.455 during the session, while it also had its lowest trading level at $3.3.
Ratios:
For a deeper understanding of Clover Health Investments Corp’s stock, let’s take a closer look at its various ratios. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Craig Hallum on December 17, 2024, initiated with a Buy rating and assigned the stock a target price of $6.
On October 07, 2024, UBS started tracking the stock assigning a Neutral rating and target price of $4.
Cowen Upgraded its Underperform to Market Perform on February 02, 2022, whereas the target price for the stock was revised from $7 to $3.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Mar 07 ’25 when Edwards Carladenise Armbrister sold 200,000 shares for $3.61 per share. The transaction valued at 722,000 led to the insider holds 273,227 shares of the business.
Priest Brady Patrick sold 75,000 shares of CLOV for $276,000 on Mar 06 ’25. The CEO of Home Care now owns 2,418,151 shares after completing the transaction at $3.68 per share. On Mar 06 ’25, another insider, Soares Karen, who serves as the General Counsel & Secretary of the company, sold 52,500 shares for $3.80 each. As a result, the insider received 199,500 and left with 1,299,663 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CLOV now has a Market Capitalization of 1684515200 and an Enterprise Value of 1516540928. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.13 while its Price-to-Book (P/B) ratio in mrq is 4.74. Its current Enterprise Value per Revenue stands at 1.02 whereas that against EBITDA is -66.207.
Stock Price History:
The Beta on a monthly basis for CLOV is 1.96, which has changed by 2.5438972 over the last 52 weeks, in comparison to a change of 0.11241627 over the same period for the S&P500. Over the past 52 weeks, CLOV has reached a high of $4.87, while it has fallen to a 52-week low of $0.86. The 50-Day Moving Average of the stock is -6.92%, while the 200-Day Moving Average is calculated to be -4.87%.
Shares Statistics:
For the past three months, CLOV has traded an average of 5.97M shares per day and 6677940 over the past ten days. A total of 388.51M shares are outstanding, with a floating share count of 380.95M. Insiders hold about 24.92% of the company’s shares, while institutions hold 18.55% stake in the company. Shares short for CLOV as of 1745971200 were 13675507 with a Short Ratio of 2.29, compared to 1743379200 on 12044344. Therefore, it implies a Short% of Shares Outstanding of 13675507 and a Short% of Float of 3.39.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
